The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

The efficacy of anti-EGFR therapy across different lines of treatment in RAS wild-type left-sided metastatic colorectal cancer.

Anita  Archwamety

No Relationships to Disclose

Charuwan  Akewanlop

Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca/MedImmune; Roche

Krittiya  Korphaisarn

Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; MSD Oncology; Takeda

Speakers' Bureau - Amgen; AstraZeneca; MSD Oncology; Roche; Takeda

Research Funding - AstraZeneca (Inst); BeiGene (Inst); MSD Oncology (Inst); Roche (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Eisai; MSD Oncology; Roche; Zuellig Pharma